期刊文献+

扶正祛邪与免疫靶向卵巢癌干细胞 被引量:4

Strengthening Body Resistance and Eliminating Evil and Immune Targeting of Ovarian Cancer Stem Cells
下载PDF
导出
摘要 目前已在卵巢癌细胞株、疫卵巢癌组织及晚期卵巢癌患者腹水中发现了卵巢癌干细胞,并证实可能参与卵巢癌的发生发展,是卵巢癌转移、复发和逃逸免化疗机制的根源。随着对卵巢癌干细胞生物学行为的深入研究,有望产生新的治疗策略,其中用免疫方法靶向卵巢癌干细胞可能成为一种重要手段。中医在临床上治疗卵巢癌的原则以扶正固本,祛毒攻邪为主,从而提高机体的免疫功能。可在用免疫方法靶向卵巢癌干细胞治疗卵巢癌中发挥重要作用。 Currently ovarian cancer stem cells were found in ovarian cancer cell line, ovarian cancer and patients with advanced ovarian cancer ascites, it may he involved in the tumorigenesis of ovarian cancer, and it is the root of metastatic ovarian cancer, recurrence and escape from chemotherapy mechanism. With the deep research on the biological behavior of ovarian cancer stem cells, new treatment strategies were expected to produced, immunological methods targeting ovarian cancer stem cells may be an important measure. The clini- cal principle of the treatment of ovarian cancer in Chinese medicine is strengthening body resistance and eliminating evil, so as to improve the body's immune function. Chinese medicine may play an important role in the treatment of ovarian cancer cells to ovarian cancer by immune method in target.
出处 《中国中医药现代远程教育》 2015年第7期149-151,共3页 Chinese Medicine Modern Distance Education of China
基金 国家自然基金项目(No:81303123) 中国博士后基金项目(No:2013T60770 2012M511382) 湖南省重点实验室开放基金(No:2014XNFZ06) 湖南中医药大学大学生研究性学习与创新性实验项目(No:201406) 湖南省大学生创新训练中心资助 中西医结合基础湖南省重点学科资助 湖南中医药大学重点学科病理学及病理生理学资助
关键词 扶正祛邪 免疫治疗 靶向治疗 卵巢癌 肿瘤干细胞 综述 strengthening body resistance and eliminating evil immune therapy targeted therapy ovarian cancer tumor stem cell review
  • 相关文献

参考文献25

  • 1王熙月,韩凤娟,吴效科,侯丽辉,闫忠鑫.中药诱导卵巢癌细胞凋亡机制及研究进展[J].中国中西医结合杂志,2012,32(1):131-133. 被引量:10
  • 2Jemal A, Murray T. Cancer statistics[J]. CA Cancer J Clin, 2005,55(1): 10-30.
  • 3Al-Hajj M, Wicha MS. Prospective identification of tumorigenic breast cancer cells [J]. Proc Natl Acad Sci USA, 2003,100(7):3983-3988.
  • 4Singh SK, Clarke ID. Identification of a cancer stem cell in human brain tumors[J]. Cancer Res, 2003,63(18):5821-5828.
  • 5Galli R, Binda E, Orfanelli U. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblasstoma[J]. Cancer Res, 2004,64 (19):7011-7021.
  • 6Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nat Med, 1997,3(7):730- 737.
  • 7Bapat SA, Mali AM. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer [J]. Cancer Res, 2005, 65(8):3025- 3029.
  • 8Challen GA, Little MH. A side order of stem cells: the SP phenotype [J]. Stem Cells, 2006, 24:3-12.
  • 9Szotek PP, Pieretti-Vanmarcke R, Massiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Munerian in- hibiting substance responsiveness [J]. Proenatl Acad Sei USA, 2006,103(30): 11154-11159.
  • 10Moserle L, Indraccolo S, Ghisi M, et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects[J]. Cancer Res, 2008,68 (14):5658-5668.

二级参考文献71

共引文献59

同被引文献274

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部